Episode
Beyond the Drip: Inside IgNS National Conference, the Super Bowl of Ig Therapy
- Podcast
- Beyond the Drip Podcast
- Published
- Oct 2, 2025
- Duration seconds
- 3918
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/beyond-the-drip-podcast-6943564/episodes/beyond-the-drip-inside-igns-national-conference-the-super-bowl-of-ig-therapy/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/beyond-the-drip-podcast-6943564/beyond-the-drip-inside-igns-national-conference-the-super-bowl-of-ig-therapy.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Beyond the Drip: Elevating Ig Therapy Through Education and Standards Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In episode 12 of Beyond the Drip, hosts Jon Love, Paula Roth, Brandon Carpenter, Pam McIntyre and Brian O’Sullivan welcome Luba Sobolevski, CEO and founder of IgNS, and Chief Clinical Officer Amy Clarke to discuss the evolving world of immunoglobulin (Ig) therapy and the 14th annual IgNS conference. The conversation highlights why IgNS was founded: to fill critical gaps in clinician education and standardize practices for a complex, lifelong therapy. Unlike fields such as oncology, Ig therapy historically offered limited training, leaving nurses and pharmacists underprepared to manage patient care and navigate regulatory and payer requirements. The IgNS conference, often called the “Super Bowl” of Ig therapy, brings together every sector of the industry from manufacturers and distributors to clinicians, pharmacists and infusion centers. Attendees can choose from business and clinical tracks, gaining guidance on revenue cycle management, documentation and legally defensible standards of practice. The discussion also explores how AI and technology are transforming care, from speech-to-text documentation and data analysis to wearable monitoring, while emphasizing that clinical judgment remains irreplaceable. Patient-focused initiatives, including education and surveys, ensure standards translate into safer, more effective…